JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taverna, S.
Right arrow Articles by Avanzini, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taverna, S.
Right arrow Articles by Avanzini, G.

Vol. 288, Issue 3, 960-968, March 1999

Inhibition of Transient and Persistent Na+ Current Fractions by the New Anticonvulsant Topiramate

S. Taverna, G. Sancini, M. Mantegazza, S. Franceschetti and G. Avanzini

Istituto Neurologico C. Besta, Milano, Italy


    Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The actions of the antiepileptic drug topiramate (TPM) on Na+ currents were assessed using whole-cell patch-clamp recordings in dissociated neocortical neurons and intracellular recordings in neocortical slices. Relatively low TPM concentrations (25-30 µM) slightly inhibited the persistent fraction of Na+ current in dissociated neurons and reduced the Na+-dependent long-lasting action potential shoulders, which can be evoked in layer V pyramidal neurons after Ca++ and K+ current blockade. Conversely, the same drug concentrations were ineffective in reducing the amplitude of the fast Na+-dependent action potentials evoked in slices or the peak of transient Na+ (INaf) current evoked in isolated neurons from a physiological holding potential. Consistent INaf inhibition became, however, evident only when the neuronal membrane was kept depolarized to enhance resting Na+ channel inactivation. TPM (100 µM) was ineffective on the voltage dependence of activation but induced a leftward shift of the steady-state INaf inactivation curve. The drug-induced inhibitory effect increased with the duration of membrane depolarization, and the recovery of INaf after long membrane depolarizations was slightly delayed in comparison with that observed under control conditions. The obtained evidence suggests that the anticonvulsant action of TPM may operate by stabilizing channel inactivation, which can be induced by depolarizing events similar to those occurring in chronic epileptic conditions. Concurrently, the slight but significant inhibition of the persistent fraction of the Na+ current, obtained with the application of relatively low TPM concentrations, may contribute toward its anticonvulsant effectiveness by modulating the near-threshold depolarizing events that are sustained by this small current fraction.


    Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Topiramate [TPM; 2,3:4,5-bis-O-(1-methyl-ethylidene)-36-D-fructopyranose sulfamate] is a novel anticonvulsant drug that has recently been licensed for clinical use in many European countries. Traditional animal tests indicate that it primarily acts by blocking the spread of seizure activity and that it has an anticonvulsant profile similar to that of phenytoin and carbamazepine (Shank et al., 1994). Accordingly, the clinical efficacy of TPM has been particularly established in patients with simple or complex partial seizures (Rosenfeld et al., 1997; Sachdeo et al., 1997), which are also known to respond to phenytoin and carbamazepine (Heller et al., 1995). The basic mechanism of action of TPM has been investigated in various experimental preparations, and preliminary results indicate that both excitatory (Coulter et al., 1993, Severt et al., 1995) and inhibitory (Brown et al., 1993; White et al., 1997) chemical neurotransmission can be modulated by the drug. Furthermore, TPM has been found to be capable of inhibiting repetitive firing and spontaneous bursting in cultured hippocampal neurons (Coulter et al., 1993), thus suggesting that it may act through a use-dependent inhibition of Na+ channels, like several other antiepileptic agents that have been shown to inhibit sustained firing in central neuron preparations (McLean and Macdonald, 1986). Direct evidence of the TPM action on transient Na+ current (INaf) was recently provided by Zona et al. (1997), showing that in cultured cerebellar neurons, this drug induces a voltage-dependent inhibition that becomes evident at depolarized membrane potentials.

A significant effect on Na+ currents has been demonstrated for several other "traditional" and "new" antiepileptic drugs, such as phenytoin, carbamazepine, valproate (Matsuki et al., 1984; Willow et al., 1985; Kuo and Bean, 1994a; Ragsdale et al., 1996), and lamotrigine (Cheung et al., 1992; Xie et al., 1995; Kuo and Lu, 1997). Together, these findings suggest that Na+ current inhibition may play a primary role in the mechanism of action of antiepileptic drugs, especially those that are effective against partial seizures. Experimental evidence suggests that antiepileptic drugs, such as phenytoin, carbamazepine (Matsuki et al., 1984; Willow et al., 1985; Kuo and Bean, 1994a; Ragsdale et al., 1996), and lamotrigine (Xie et al., 1995) exert a voltage-dependent effect on voltage-gated Na+ channels by preferentially acting on inactivated channels. This suggests that their inhibitory action is turned on by long-lasting depolarizing potentials, similar to those characterizing epileptic ictal phenomena, leaving the generation of physiological Na+-dependent action potentials (APs) unaffected.

An additional antiepileptic mechanism affecting Na+ currents was recently proposed by Chao and Alzheimer (1995) for phenytoin, which was found to selectively reduce the persistent fraction of Na+ currents (INaP) at concentrations lower than those capable of reducing the peak of the fast Na+ current. Because this small fraction of the Na+ current is known to play an important role in regulating the firing characteristics of neocortical pyramidal neurons (Stafstrom et al., 1985; Franceschetti et al., 1995; Crill, 1996; Fleidervish and Gutnick, 1996; Guatteo et al., 1996, Mantegazza et al., 1998) and has been found to contribute to the generation of epileptiform activity (Segal and Douglas, 1997), it can be considered to be a further significant target when studying the Na+ channel-operated effects of new antiepileptic drugs. We here report the results of voltage-clamp experiments performed on acutely dissociated neocortical neurons, with the aim of investigating the effects of TPM on both the transient and persistent components of Na+ current. Control intracellular recordings to verify the drug effect on neocortical neurons were made using slice experiments

    Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Slice and Cell Preparation. Ten- to 20-day-old Wistar rats (Charles River, Italy) were anesthetized with chloral hydrate (Fluka AG, Buchs, Switzerland) and decapitated. Then brains were removed and placed in ice-cold artificial cerebrospinal fluid (ACSF) of the following composition: 120 mM NaCl, 24 mM NaHCO3, 1 mM CaCl2, 1 mM NaHPO4, 4 mM MgCl2, 2.5 mM KCl, and 20 mM glucose, bubbled with 95% O2 and 5% CO2. Coronal slices with a thickness of 300 to 350 µm were cut from the dorsal frontoparietal cortex using a vibratome. The slices used for the current-clamp experiments were transferred to an interface chamber, perfused with ACSF, and allowed to equilibrate for 1 to 1.5 h before the electrophysiological recordings were started. The dissociated neurons for the patch-clamp experiments were prepared from slices kept for 10 to 15 min in modified ACSF [in which NaHCO3 was partially substituted with 10 mM HEPES-NaOH bubbled with 95% O2 and 5% CO2 at 35°C, pH 7.4] with the addition of 1 mM kynurenic acid and 1 mg/ml Protease Type XIV to digest the extracellular matrix; after enzyme treatment, the slices were washed and stored in an enzyme-free solution. At the recording time, the neurons were dissociated using fire-polished Pasteur pipettes, plated in a Petri dish (Costar Corp., Cambridge, MA), left 3 to 5 min to allow attachment, and then bath perfused with modified ACSF (see below). Only large neurons with a pyramidal shape were selected for patch-clamp recordings.

Electrophysiological Recordings. The intracellular recordings in slices were performed on layer V pyramidal neurons using an IR-283 (Neuro Data Inst. Corp., New York) amplifier. Sharp electrodes were prepared using borosilicate glass capillaries (Clark Electromedical Inst.) and filled with 3 M K+ acetate (resistance 80-90 MOmega ). Only healthy neurons with a stable spontaneous resting membrane potential (Vrest) that was more negative than -60 mV, a stable firing level and overshooting APs were selected for the analysis. Voltage and current signals were displayed on a Tektronix storage oscilloscope and stored on a magnetic tape. To isolate the Na+ currents, after neuron impalement the slices were bath perfused by a solution of 60 mM NaCl, 60 mM tetraethylammonium Cl, 0.2 mM CaCl2, 7 mM MgCl2, 2 mM CdCl2, 24 mM NaHCO3, and 10 mM glucose (pH 7.4), bubbled with 95% O2 and 5% CO2.

Whole-cell recordings in isolated neurons were performed at room temperature using a RK 400 Patch Clamp Amplifier (BioLogic). The data were digitized by means of a Digidata 1200 interface (Axon Instruments, Burlingame, CA), and pClamp 6.0 software (Axon Instruments) was used to generate stimulus protocols and signal acquisition. Access resistance ranged from 5 to 10 MOmega , linear leakage and capacitative currents were minimized by means of the amplifier circuitry; junction potential errors were not corrected, and the remaining leakage currents were eliminated using the P/4 subtraction protocol; the membrane currents were filtered at 3 kHz (voltage steps) or 1 kHz (voltage ramps). The data were analyzed using pClamp and Origin 4.0 (Microcal Inc.) software on a Pentium 166 PC.

To record the Na+ currents, borosilicate glass electrodes were filled with 75 mM CsF, 55 mM CsCl, 1 mM MgCl2, 10 mM ethylene glycol bis(beta -aminoethyl ether)-N,N,N',N'-tetraacetic acid-CsOH, 10 mM HEPES-CsOH, 2 Na2ATP, 10 mM phosphocreatine-di-Tris, and 20 units/ml creatine phosphokinase, pH 7.2 (2-3 MOmega ), and the neurons were bath perfused with a modified ACSF containing 120 mM NaCl, 1.3 mM CaCl2, 2 mM MgCl2, 0.4 mM CdCl2, 0.3 mM NiCl2, 20 mM tetraethylammonium, 10 mM HEPES-NaOH, and 10 mM glucose, pH 7.3, bubbled with pure oxygen. In the experiments aimed at recording fast Na+ currents, NaCl was lowered to 10 mM and partially substituted with choline-Cl (110 mM) to avoid voltage-clamp errors. The statistical results are given as mean ± S.E.M. values; statistical significance was evaluated using the two-tailed Student's t test for paired data.

TPM (The R.A.W. Johnson Pharmaceutical Research Institute, Rarity, NJ) was dissolved in water at a concentration of 20 mM and stored at -20°C; at the recording time, the drug was dissolved in the perfusing solutions. In the dissociated neurons, TPM was bath applied at concentrations ranging from 10 to 200 µM; in the slices, TPM was added to ACSF at concentrations of 30 and 100 µM.

    Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Using the whole-cell configuration of the patch-clamp technique, voltage-clamp recordings were obtained from 40 pyramidal neurons acutely dissociated from rat sensorimotor cortex slices. The intracellular recordings in current-clamp configuration were made in 9 pyramidal neurons of layer V in slices of sensorimotor cortex.

In preliminary experiments, rather high TPM concentrations (100-400 µM) were tested on the Na+-dependent APs generated by isolated neocortical neurons, which were recorded in current-clamp configuration and stimulated by brief (1.5-ms) depolarizing current pulses. The main drug effect was a reduction in the long-lasting AP shoulder (Fig. 1), which becomes visible after K+ and Ca++ current blockade and is sustained by INaP (Stafstrom et al., 1985); with 200 µM TPM concentration, the duration of AP shoulder was reduced from 32.1 ± 8.1 to 19.2 ± 6.3 ms (n = 3). Voltage-clamp experiments on dissociated neurons then were carried out to further characterize the effects of TPM on both the transient and persistent components of Na+ currents and to establish the effective drug concentration.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1.   Effect of TPM 200 µM on an AP shoulder evoked in response to a brief depolarizing pulse (top trace) in a dissociated neocortical neuron and recorded in current-clamp configuration after K+ and Ca++ currents blockade. Holding potential, -85 mV.

TPM Effect on Persistent Fraction of Na+ Current. A first series of experiments was designed to evaluate the effect of TPM on the persistent fraction of Na+ current (INaP), which was evoked in dissociated pyramidal neurons using slowly rising ramps as voltage stimuli. Depolarizing ramp potentials (from -70 to +10 mV at a rate of 80 mV/s), which were slow enough to avoid transient Na+ channel opening, were consistently capable of evoking a small inward TTX-sensitive Na+ current, which is considered to be accounted for by INaP (Alzheimer et al., 1993; Brown et al., 1994). The INaP in cortical neurons typically begins to activate between -60 and -50 mV and has a broad peak at about -40 mV (Fig. 2A), as previously found by French et al. (1990), Alzheimer et al. (1993), and Brown et al. (1994). A contaminating outward current (Fig. 2A), which was insensitive to the K+ blockers and remained after the addition of 1 µM TTX, was frequently found to activate at more positive potentials (more than -25 mV) and was assumed to correspond to the cationic current described by Alzheimer (1994) in neocortical neurons.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2.   A, INaP evoked by a slow voltage ramp stimulus (top trace) in a representative neuron, under control solution and in the presence of 25 µM TPM. B, percentage inhibition of INaP peak amplitude evaluated on six neurons. Inhibition percentages obtained at each concentration were fitted using a Hill equation (see text).

TPM added to the superfusing medium at concentrations ranging from 25 to 400 µM was capable of inhibiting INaP in a dose-dependent fashion. The percentage of inhibition of INaP peak amplitude obtained after bath perfusion at different TPM concentrations is plotted in Fig. 2B. The points represent the averaged values obtained from five cells, fitted with the Hill equation: E/Emax = [TPM]n/([TPM]n +EC50n), where E/Emax is the relative effect, [TPM] is the drug concentration, and EC50 is the dose at which a half-maximum effect is obtained. The fitting curve revealed an EC50 = 71 ± 6 µM, an Emax = 66 ± 2%, and a Hill coefficient of 0.97 ± 0.05, thus indicating a 1:1 ratio between the number of drug molecules and channel binding sites.

Effect of TPM on Transient Na+ Current (INaf). The experiments were performed after partially substituting NaCl with choline-Cl (see Materials and Methods) to reduce voltage-clamp errors due to the large INaf observed in pyramidal neocortical neurons. Under this conditions, the maximum peak amplitude of INaf never exceeded 2.5 nA (range, 0.4-2.5 nA).

INaf was evoked by means of families of 200-ms depolarizing step potentials up to +55 mV, delivered from a holding potential of -70 mV, close to the spontaneous Vrest found in neocortical pyramidal neurons recorded in slices (-68.4 ± 4.3 mV) (Franceschetti et al., 1995, 1998), or from a hyperpolarized (-90 mV) or depolarized (-60 mV) holding potential to change the fraction of inactivated Na+ channels and therefore to evaluate the influence of the resting Na+ channel inactivation on effect of TPM.

The lower TPM concentration (30 µM) used in these experiments was unable to inhibit INaf when the test pulses were delivered from a holding potential of -70 mV (Fig. 3A) but did so slightly and consistently when the test pulses were delivered from a depolarizing holding of -60 mV (Fig. 3B). The normalized current/voltage relationship evaluated using step depolarizations delivered from -60 mV holding is shown in Fig. 3C. The maximum INaf peak amplitude typically evoked in response to depolarizing test pulses to -15 mV was reduced by 20.0 ± 0.1% in the presence of TPM (four neurons).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   INaf evoked under control conditions and after 30 µM TPM in a representative neocortical neuron perfused by low-Na+ ACSF (see text). No inhibition was found when INaf was evoked from holding potential of -70 mV (A), but a slight reduction became evident (B) when test pulse was evoked from -60 mV. C, normalized current-voltage plot of INaf (Control, triangle ; TPM, bullet ) evoked from holding potential of -60 mV (n = 4).

As shown in a representative neuron (Fig. 4,A-C), in the presence of 100 µM TPM, a slight inhibition of the maximal INaf amplitude also became visible when the current was `evoked from a -70-mV holding potential (23 ± 4%; four neurons) and considerably increased (reaching 42 ± 6%; five neurons) when the membrane potential was held at -60 mV; however, the inhibitory effect was prevented when the membrane was hyperpolarized to -90 mV (n = 3) to deinactivate most of the Na+ channels before evoking INaf


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of 100 µM TPM on INaf peak amplitude and on activation and steady-state inactivation of Na+ channels. A-C, INaf evoked as described in Fig. 3, under control conditions and in the presence of 100 µM TPM. The drug was capable of slightly inhibiting the INaf evoked in a neuron held at -70 mV (A); degree of inhibition increased when holding rose to -60 mV (B) but was prevented when membrane potential was hyperpolarized to -90 mV to deinactivate most of the Na+ channels (C). D, in the presence of 100 µM of TPM (bullet ), voltage-dependence curve of activation of Na+ channels (four neurons) did not significantly differ from that evaluated under control conditions (triangle ). E, steady-state inactivation curve under control conditions and in the presence of 100 µM TPM (four neurons). Peak values of INaf were plotted against prepulse potentials and fitted using a Boltzmann relationship, showing a significant drug-induced leftward shift in V1/2 without any significant changes in slope factor (labels as in D).

Effect of TPM on Activation and Inactivation of Na+ Channels. The voltage dependence of Na+ channel activation appeared to be unaffected by both 30 µM (not shown) and 100 µM TPM. The fast activation curves of the Na+ channels evaluated under control conditions and in the presence of 100 µM TPM in four neurons held at -60 mV are shown in Fig. 4D. The conductance of the Na+ channels (GNa) was calculated by the equation GNa = INaf/(V - VNa), where INaf is the maximal inward current, V is the command potential, and VNa is the theoretical reversal potential (calculated by means of the Nernst equation to be +33.8 mV with 15 mM Na+ in the external solution). The normalized conductance (G/Gmax) was plotted against the command potential following the Boltzmann relation: G/Gmax = 1/(1 + exp[(V1/2 - V)/k]), where G/Gmax is the relative conductance, V1/2 is the voltage at which half-maximal activation is reached, and k is the slope factor. Under control conditions, the half-maximal activation potential (V1/2) was -18.2 mV and k was 9.2 mV/e-fold; in the presence of 100 µM TPM, V1/2 was -20.0 mV and k was 8.9 mV/e-fold.

The voltage dependence of steady-state inactivation was evaluated using 300-ms prepulse potentials varying from -105 to -45 mV before depolarizing test pulses to -15 mV to evoke INaf. Under control conditions and in the presence of 100 µM TPM, the steady-state inactivation curve could be fitted using the Boltzmann equation: I/Imax =1/(1 + exp[(V - V1/2)/k]). The addition of the drug caused a hyperpolarizing shift of the curve, without inducing any significant changes in its slope factor. The mean values of V1/2 evaluated on four neurons (Fig. 4E) were -62.1 ± 0.4 mV under control conditions and -69.1 ± 0.2 mV in the presence of 100 µM TPM (p < .05); the value of k was 5.7 mV/e-fold change under control conditions and 5.9 mV/e-fold in the presence of TPM.

To investigate the time dependence of the effect of TPM on INaf, we applied a stimulus protocol that included progressively longer (from 240-800 ms in 55-ms steps) depolarizing prepulses to -45 mV delivered before the depolarizing test pulses to -15 mV. A short (40-ms) hyperpolarizing current pulse to -90 mV was delivered at the end of the depolarizing prestimulus with the aim of removing fast inactivation. As shown in Fig. 5A, the INaf peak values elicited by the test pulses under control conditions progressively declined in line with the increase in the duration of the depolarizing prepulse; this can be attributed to incoming slow inactivation. In the presence of TPM (Fig. 5B), the decline in INaf peak amplitudes was greatly enhanced. In Fig. 5C, the mean values obtained in three neurons are plotted against the length of the conditioning pulses; the measured INaf peak amplitudes were normalized with respect to the maximal current, obtained after the first delivered prepulse (240 ms). Under control conditions and in the presence of the drug, the values of the INaf peak amplitude could be fitted using a single exponential function. The time constant of the exponential fitting was found to be slightly slower in the presence of the drug (344.6 ± 39.4 versus 258.2 ± 49.2 ms), thus indicating an increase in the drug action in parallel with the development of channel inactivation.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 5.   Time-dependent TPM inhibitory effect on INaf on a representative neuron. Under control conditions, the INaf peak appears to be slightly decreased by incoming slow inactivation (A); in the presence of TPM 100 µM, inhibition was greatly enhanced (B). C, plot of peak INaf values versus prepulse length. Inset, stimulus protocol. Peak values of INaf were normalized to amplitude of current evoked after first inactivating prepulse. Time courses were fitted by the exponential equation: y = y0 + A exp[-(t - t0)/tau ], where y0 is offset value, A is peak relative amplitude at t = t0 (corresponding to first pulse of 240 ms), and tau  is decay time constant. Under control conditions, y0 was 0.73 ± 0.02 and tau  was 258.2 ± 49.2 ms; in presence of the drug, y0 was 0.21 ± 0.04 and tau  was 344.6 ± 39.4 ms. D, change in time course of recovery from inactivation in the presence of 100 µM TPM; holding potential was -70 mV. Inset, stimulus protocol. Peak current amplitudes at various times of recovery were measured and plotted (control, triangle ; TPM, bullet ). To fit the data points, the following monoexponential equation was used: y = y0 + A[1 - exp(-t/tau )]. Under control conditions, y0 = 0.63 ± 0.02 and tau  = 70.63 ± 11.2 ms; with 100 µM TPM, y0 = 0.55 ± 0.02 and tau  = 182.4 ± 46.2 ms.

The TPM effect on the recovery from Na+ current inactivation was evaluated by evoking INaf after a long-lasting (715-ms) depolarizing conditioning pulse to -10 mV, followed by a deinactivating hyperpolarizing prepulse to -90 mV of progressively increasing length. Both under control conditions and in presence of the drug, the time course of recovery could be fitted using a single exponential function (Fig. 5D). The control tau  value of 70.6 ± 11.2 ms increased to 182.4 ± 46.2 ms after the addition of the drug.

Effect of TPM on Na+-Dependent Potentials Recorded in Slices. The intrinsically bursting neurons recorded in slice experiments were perfused with 30 and 100 µM TPM dissolved in bath solution. When most of the hyperpolarizing K+ currents were blocked by means of a high extracellular TEA concentration (40 mM) and the Ca++-dependent K+ currents were blocked by substituting Ca++ ions with Co++ or Mn++, the intrinsically bursting pyramidal neurons discharged with a fast AP followed by a very long depolarizing shoulder arising from AP repolarizing phase at about -20 mV and lasting 800 to 2000 ms. The neurons were left at spontaneous Vrest (-65.5 ± 0.7 mV) and small changes in membrane potential, occasionally occurring during the recording time, were adjusted to the control Vrest by injecting weak DC currents. TPM 30 µM did not modify the amplitude and shape of the fast Na+-dependent AP (Fig. 6A) but consistently shortened the depolarizing shoulders (Fig. 6B); the length of the depolarizing shoulders was 1347 ± 650 ms under control conditions (mean of four sweeps measured on six neurons), 782.5 ± 403.0 ms during the addition of TPM (p < .02), and recovered during wash-out (1083.9 ± 560 ms, p = .68). Conversely, TPM 100 µM slightly decreased the peak amplitude of the AP (Fig. 6A) and induced a progressive reduction to the point of almost complete suppression of the long-lasting depolarizing plateau after AP activation (Fig. 6B).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of TPM on AP and AP shoulders recorded in slices. A, amplitude and time course of fast AP was unaffected by 30 µM TPM, but a slight decrease in amplitude concurrent with a slower time to rise (see first derivatives in inset) became evident when slices were perfused with 100 µM TPM. B, in same neuron reported in A, AP shoulder was evidently shortened during perfusion of 30 µM TPM and almost completely suppressed when drug concentration rose to 100 µM.

    Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The data from this study demonstrate that relatively low TPM concentrations are capable of significantly inhibiting both the fast and persistent components of Na+ currents in neocortical neurons: 25 to 30 µM TPM concentrations were found to inhibit INaP by about 20% in dissociated neocortical neurons and to reduce the INaf peak amplitude provided that it was evoked from a slightly depolarized holding potential. The therapeutic values of TPM blood levels have been little investigated in clinical trials; however, the little published data indicate that the single (Johannessen, 1997) or chronic (Perucca, 1997) administration of an effective daily dose of 400 to 1200 mg/day give rise to plasma levels ranging from 4 to 10 µg/ml, which are very close to the lower TPM concentrations used in the present study.

The evidence that relatively low TPM concentrations principally inhibit the persistent fraction of Na+ current when the neurons were stimulated starting from their spontaneous Vrest, currently close to -70 mV (Tseng and Prince, 1993; Franceschetti et al., 1995, 1998), is supported by the results obtained in the voltage-clamp experiments performed on dissociated neurons and confirmed by the current-clamp experiments on neocortical slices. TPM 30 µM did not affect "fast" APs in the layer V pyramidal neurons but consistently shortened the long-lasting AP shoulders, which are revealed by Ca++ and K+ blockade and have been attributed to INaP. Different ionic mechanisms contribute to afterdepolarization in neocortical neurons (Friedman et al., 1992; Reuveni et al., 1993) and, among them, a cationic current, sensitive to phenytoin inhibition, recently described by Kang et al. (1998). However, the large plateaux potentials that were found to be blocked by the TPM have been previously demonstrated to be sustained by a persistent TTX-sensitive Na+ current (Stafstrom et al., 1985) that is prominent in layer V of IB neurons (Franceschetti et al., 1995).

It has been shown that INaP and INaf in neocortical neurons are generated by uniform channel population that can switch to different gating modes, so INaP can be sustained by the small fraction of Na+ channels that fail to inactivate despite membrane depolarization, thus giving rise to sustained burst of channel openings (Alzheimer et al., 1993; Brown et al., 1994). This opening mode can be activated by a slow rising depolarization (such as that induced by a slow ramp potential) and has been shown to underlie the depolarizing plateaux potentials that spontaneously occur in an in vitro model of seizure-like activity obtained in cultured hippocampal neurons (Segal, 1994; Segal and Douglas, 1997). Stabilization of Na+ channels in their inactivated state could prevent their late opening and thus account for the TPM-induced inhibition of INaP that we found in both dissociated neurons and slices. Moreover, our results with TPM agree with those previously obtained with phenytoin, which, at concentrations significantly lower than those needed to inhibit the INaf, has been found to reduce INaP amplitude in dissociated neocortical neurons (Chao and Alzheimer, 1995) and to prevent the late channel opening in the above-mentioned model of ictal epileptiform activity obtained in hippocampal neurons (Segal and Douglas, 1997).

Binding to the inactivated state of Na+ channels, capable of preventing any transition that would allow channel reopening, could account not only for the effect of TPM on INaP but also for most of its effects on INaf, which can be revealed by means of different inactivating procedures. This assumption is further supported by the finding that membrane hyperpolarization at -90 mV, which is suitable for removing most of the channel inactivation, was sufficient to prevent drug activity even when it was added at higher concentrations (100 µM). Experiments aimed at further clarifying the dynamics and the mechanisms through which TPM can influence Na+ channels were performed using a 100 µM drug concentration, which in our study approximated the concentration that inhibits the persistent fraction of Na+ current by about 50% and also was sufficient to slightly inhibit the INaf peak in neocortical neurons held at -70 mV. In the presence of the drug, the steady-state INaf inactivation curve was found to be significantly shifted to more hyperpolarized potentials without any significant slope changes. This suggests that TPM binding is capable of preventing channel transition from an inactivated to a deinactivated state during the depolarizing prepulse and that less positive subthreshold depolarizing events are needed to decrease Na+-mediated membrane excitability. A leftward shift in steady-state inactivation has been previously reported to be induced by several anticonvulsants and by other drugs acting on Na+ channels (i.e., antiarrhythmic agents and local anesthetics) (Willow et al., 1985; Kuo and Bean, 1994a; Ragsdale et al., 1996); moreover, it has been found to occur in cultured granular neurons exposed to TPM (Zona et al., 1997), thus further indicating that drugs capable of controlling intrinsic membrane excitability can act by favoring steady Na+ channel inactivation.

The effect of TPM on INaf was not only voltage but also time dependent: drug-induced inhibition of INaf regularly increased when the neuronal membrane was kept depolarized by progressively longer conditioning prepulses at -40 mV. Furthermore, the recovery from the inactivation appeared to be slower in the presence of the drug than under control conditions. Both of these effects may be attributable to preferential drug binding on the slowly inactivated channel state, which is known to occur during long-lasting depolarizations (Ruben et al., 1992), or conversely, they could be due to slowly occurring binding and unbinding to the fast inactivated or closed but "activated" channel states, as proposed by Kuo and Bean (1994b). According to the hypothesis formulated by these authors to elucidate the action of phenytoin (which is the more extensively studied of the anticonvulsants acting on Na+ channels), drug binding may be slow but tight to the "activated" channels (i.e., channels with at least one gating charge in the "on" position), thus supporting the time-dependent increase in the inhibitory effect and the delayed recovery in response to a deinactivating hyperpolarization. Different anticonvulsant molecules might have different affinities for the activated Na+ channels (or different speeds of binding and unbinding), which can establish the time course of drug action and presumably imply differences in therapeutic effects (Kuo and Lu, 1997).

TPM-induced INaf inhibition regularly increased with the length of the depolarizing prepulses, as has also been reported for phenytoin (Kuo and Bean, 1994a), but the recovery due to deinactivating hyperpolarizing pulses was found to be more rapid than that associated with phenytoin and apparently comparable to that of carbamazepine and lamotrigine (Xie et al., 1995; Kuo et al., 1997). This suggests that the drug may regularly increase its effectiveness during long-lasting depolarizing events by adding to the normally occurring slow Na+ channel inactivation, whereas its effect may be more quickly removed by incoming hyperpolarizations, which can be sustained by either synaptic inhibition or hyperpolarizing currents.

Na+ Current Inhibition as an Antiepileptic Effect of TPM. TPM has been reported to possess multiple mechanisms of action and to be capable of modifying both gamma -aminobutyric acidA- and kainate-evoked ion flow at very low concentrations (Severt et al., 1995; White et al., 1997), and the drug probably can act on different seizure types throughout its different effects (see Perucca, 1997, for review). The present data show that like some other anticonvulsants known to be especially effective against focal seizures, TPM can inhibit Na+ currents, and that this action may occur at potentially therapeutic concentrations. Moreover, there is evidence to indicate that such relatively low drug concentrations should not significantly affect the physiological generation APs in well polarized neurons, and the drug action would come into play as much as sustained depolarizing events or high-frequency AP discharges are capable of reducing the fraction of the "resting" Na+ channels. Possible contribution toward controlling membrane hyperexcitability comes from the ability of TPM to inhibit INaP because the channel opening mode sustaining this current fraction may play a part in the generation of ictal events (Segal, 1994). Moreover, because INaP starts activating at more negative potentials than INaf (French et al., 1990; Alzheimer et al., 1993; Segal and Douglas, 1997), its inhibition may prevent membrane depolarizations before a neuron starts to fire. Furthermore, a TPM-induced limitation of the intrinsic INaP dependent bursting behavior may contribute significantly to reduce epileptic synchronization (Chagnac-Amitai and Connors, 1989).

The time-dependent enhancement of TPM-induced Na+ channel blockade found to take place during long-lasting depolarizations may be especially suitable for limiting the paroxysmal depolarizing plateau and/or prolonged AP discharges known to occur in epileptic aggregates (Segal, 1994). On the other hand, the rather fast unbinding of the drug during INaf recovery from inactivation could be considered a favorable characteristic allowing the neurons involved in epileptic events to restore their physiological function as soon as the events are terminated by the K+-dependent hyperpolarizing afterpotentials ordinarily occurring in epileptic aggregates and lasting hundreds of milliseconds (see Dichter and Ayala, 1987, for review).

    Acknowledgments

The assistance of R.A.W. Johnson Pharmaceutical Research Institute in supplying TPM is gratefully acknowledged.

    Footnotes

Accepted for publication September 29, 1998.

Received for publication May 29, 1998.

Send reprint requests to: Dr. Silvana Franceschetti, Istituto Neurologico C. Besta, Department of Neurophysiology, via Celoria 11, 20133 Milano, Italy. E-mail: franceschetti{at}istituto-besta.it

    Abbreviations

INaf, transient sodium current; INaP, persistent sodium current; TPM, topiramate; ACSF, artificial cerebrospinal fluid; AP, action potential; TTX, tetrodotoxin.

    References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References


0022-3565/99/2883-0960$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
BrainHome page
S. Remy and H. Beck
Molecular and cellular mechanisms of pharmacoresistance in epilepsy
Brain, January 1, 2006; 129(1): 18 - 35.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
A. M Chung and M. D Reed
Intentional Topiramate Ingestion in an Adolescent Female
Ann. Pharmacother., September 1, 2004; 38(9): 1439 - 1442.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. Z. Wetmore and S. N. Baker
Post-spike distance-to-threshold trajectories of neurones in monkey motor cortex
J. Physiol., March 15, 2004; 555(3): 831 - 850.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. S. Gryder and M. A. Rogawski
Selective Antagonism of GluR5 Kainate-Receptor-Mediated Synaptic Currents by Topiramate in Rat Basolateral Amygdala Neurons
J. Neurosci., August 6, 2003; 23(18): 7069 - 7074.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taverna, S.
Right arrow Articles by Avanzini, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taverna, S.
Right arrow Articles by Avanzini, G.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition